{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:37Z","timestamp":1791314377698,"version":"4.3.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000},"content-version":"vor","delay-in-days":201,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1038\/mt.2016.12","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T14:15:17Z","timestamp":1452780917000},"page":"965-977","source":"Crossref","is-referenced-by-count":156,"title":["Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models"],"prefix":"10.1016","volume":"24","author":[{"given":"Kari","family":"Pollock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Dahlenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle D","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Cary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geralyn","family":"Annett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Torrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nacey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Pepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos","family":"Kalomoiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathon D","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannine","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Gruenloh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Fury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Tempkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Wheelock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A","family":"Nolta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2016.12_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1038\/mt.2016.12_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Huntington Study","year":"2006","journal-title":"Neurology"},{"key":"10.1038\/mt.2016.12_bib3","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/mds.26014","article-title":"Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?","volume":"29","author":"Killoran","year":"2014","journal-title":"Mov Disord"},{"key":"10.1038\/mt.2016.12_bib4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.7150\/ijbs.9898","article-title":"Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?","volume":"10","author":"Scheuing","year":"2014","journal-title":"Int J Biol Sci"},{"key":"10.1038\/mt.2016.12_bib5","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2016.12_bib6","doi-asserted-by":"crossref","first-page":"13662","DOI":"10.1523\/JNEUROSCI.4144-08.2008","article-title":"Enhanced sensitivity of striatal neurons to axonal transport defects induced by mutant huntingtin","volume":"28","author":"Her","year":"2008","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2016.12_bib7","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1074\/jbc.M109.073197","article-title":"Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release","volume":"285","author":"Wu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2016.12_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-1-62703-411-1_2","article-title":"Huntington's disease and cell therapies: past, present, and future","volume":"1010","author":"Antoniades","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mt.2016.12_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.nbd.2007.10.003","article-title":"Disruption of striatal glutamatergic transmission induced by mutant huntingtin involves remodeling of both postsynaptic density and NMDA receptor signaling","volume":"29","author":"Torres-Peraza","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2016.12_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcn.2008.04.012","article-title":"Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347","volume":"39","author":"Conforti","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1038\/mt.2016.12_bib11","doi-asserted-by":"crossref","first-page":"6972","DOI":"10.1523\/JNEUROSCI.4278-06.2007","article-title":"Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease","volume":"27","author":"Zuccato","year":"2007","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2016.12_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients","volume":"144B","author":"Ciammola","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1038\/mt.2016.12_bib13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol Res"},{"key":"10.1038\/mt.2016.12_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1038\/mt.2016.12_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neulet.2013.11.060","article-title":"BDNF in quinolinic acid lesioned rats after bone marrow cells transplant","volume":"559","author":"Serrano S\u00e1nchez","year":"2014","journal-title":"Neurosci Lett"},{"key":"10.1038\/mt.2016.12_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1601-183X.2012.00858.x","article-title":"Relationship between BDNF expression in major striatal afferents, striatum morphology and motor behavior in the R6\/2 mouse model of Huntington's disease","volume":"12","author":"Samadi","year":"2013","journal-title":"Genes Brain Behav"},{"key":"10.1038\/mt.2016.12_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jnc.12177","article-title":"BDNF prevents NMDA-induced toxicity in models of Huntington's disease: the effects are genotype specific and adenosine A2A receptor is involved","volume":"125","author":"Martire","year":"2013","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2016.12_bib18","doi-asserted-by":"crossref","first-page":"e64037","DOI":"10.1371\/journal.pone.0064037","article-title":"Systemic delivery of recombinant brain derived neurotrophic factor (BDNF) in the R6\/2 mouse model of Huntington's disease","volume":"8","author":"Giamp\u00e0","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.12_bib19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2012.07.026","article-title":"BDNF may play a differential role in the protective effect of the mGluR2\/3 agonist LY379268 on striatal projection neurons in R6\/2 Huntington's disease mice","volume":"1473","author":"Reiner","year":"2012","journal-title":"Brain Res"},{"key":"10.1038\/mt.2016.12_bib20","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/gt.2011.114","article-title":"Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF","volume":"19","author":"Benraiss","year":"2012","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.12_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1750-1326-6-71","article-title":"Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction","volume":"6","author":"Giralt","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.1038\/mt.2016.12_bib22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10571-011-9725-y","article-title":"Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington's disease delays the onset of the motor phenotype","volume":"31","author":"Arregui","year":"2011","journal-title":"Cell Mol Neurobiol"},{"key":"10.1038\/mt.2016.12_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/hipo.20658","article-title":"Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice","volume":"20","author":"Zajac","year":"2010","journal-title":"Hippocampus"},{"key":"10.1038\/mt.2016.12_bib24","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2016.12_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00429-010-0282-9","article-title":"An intrastriatal brain-derived neurotrophic factor infusion restores striatal gene expression in Bdnf heterozygous mice","volume":"215","author":"Saylor","year":"2010","journal-title":"Brain Struct Funct"},{"key":"10.1038\/mt.2016.12_bib26","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/gt.2010.71","article-title":"BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease","volume":"17","author":"Giralt","year":"2010","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.12_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","article-title":"Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease","volume":"214","author":"Dey","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1038\/mt.2016.12_bib28","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neuro.2009.03.008","article-title":"Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons","volume":"30","author":"Wu","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1038\/mt.2016.12_bib29","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2016.12_bib30","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.neuroscience.2008.11.024","article-title":"Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCgamma activity and glutamate receptor expression","volume":"158","author":"Giralt","year":"2009","journal-title":"Neuroscience"},{"key":"10.1038\/mt.2016.12_bib31","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/gt.2008.23","article-title":"AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment","volume":"15","author":"Kells","year":"2008","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.12_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2016.12_bib33","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2016.12_bib34","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1046\/j.1471-4159.2000.0752190.x","article-title":"Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4\/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease","volume":"75","author":"P\u00e9rez-Navarro","year":"2000","journal-title":"J Neurochem"},{"key":"10.1038\/mt.2016.12_bib35","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1523\/JNEUROSCI.16-15-04604.1996","article-title":"Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically modified neural stem cells","volume":"16","author":"Mart\u00ednez-Serrano","year":"1996","journal-title":"J Neurosci"},{"key":"10.1038\/mt.2016.12_bib36","first-page":"195","article-title":"Neurotrophic factors in Huntington's disease","volume":"146","author":"Alberch","year":"2004","journal-title":"Prog Brain Res"},{"key":"10.1038\/mt.2016.12_bib37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2217\/rme.15.25","article-title":"Developing stem cell therapies for Juvenile and adult onset Huntington's disease","volume":"10","author":"Fink","year":"2015","journal-title":"Regen Med"},{"key":"10.1038\/mt.2016.12_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/ar2467","article-title":"Suppression of bone morphogenetic protein inhibitors promotes osteogenic differentiation: therapeutic implications","volume":"10","author":"Heliotis","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1038\/mt.2016.12_bib39","doi-asserted-by":"crossref","first-page":"26450","DOI":"10.1074\/jbc.M703282200","article-title":"Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation","volume":"282","author":"Wan","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2016.12_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/PRS.0b013e3182361ff5","article-title":"Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor","volume":"129","author":"Levi","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"10.1038\/mt.2016.12_bib41","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1002\/jcb.24240","article-title":"Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro","volume":"113","author":"Chen","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1038\/mt.2016.12_bib42","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12035-011-8219-8","article-title":"Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease","volume":"45","author":"Olson","year":"2012","journal-title":"Mol Neurobiol"},{"key":"10.1038\/mt.2016.12_bib43","series-title":"Establishment and Transduction of Primary Human Stromal\/Mesenchymal Stem Cell Monolayers","author":"Meyerrose","year":"2006"},{"key":"10.1038\/mt.2016.12_bib44","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.addr.2010.09.013","article-title":"Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors","volume":"62","author":"Meyerrose","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1038\/mt.2016.12_bib45","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/emm.2013.94","article-title":"Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine","volume":"45","author":"Murphy","year":"2013","journal-title":"Exp Mol Med"},{"key":"10.1038\/mt.2016.12_bib46","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/scrt516","article-title":"Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury","volume":"5","author":"Mendon\u00e7a","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1038\/mt.2016.12_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1517\/14712598.2014.866648","article-title":"Adult adherent stromal cells in the management of graft-versus-host disease","volume":"14","author":"Newell","year":"2014","journal-title":"Expert Opin Biol Ther"},{"key":"10.1038\/mt.2016.12_bib48","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/stem.1628","article-title":"Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future","volume":"32","author":"Lunn","year":"2014","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2016.12_bib49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/2046-4053-3-48","article-title":"Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol","volume":"3","author":"Lalu","year":"2014","journal-title":"Syst Rev"},{"key":"10.1038\/mt.2016.12_bib50","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2001-1326-3-24","article-title":"Stem cell delivery of therapies for brain disorders","volume":"3","author":"Aleynik","year":"2014","journal-title":"Clin Transl Med"},{"key":"10.1038\/mt.2016.12_bib51","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1089\/scd.2015.0008","article-title":"Mesenchymal stem cell therapy for autoimmune disease: risks and rewards","volume":"24","author":"Munir","year":"2015","journal-title":"Stem Cells Dev"},{"key":"10.1038\/mt.2016.12_bib52","doi-asserted-by":"crossref","first-page":"629","DOI":"10.4252\/wjsc.v6.i5.629","article-title":"Stem cell application for osteoarthritis in the knee joint: A minireview","volume":"6","author":"Uth","year":"2014","journal-title":"World J Stem Cells"},{"key":"10.1038\/mt.2016.12_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4252\/wjsc.v6.i2.111","article-title":"Progress of mesenchymal stem cell therapy for neural and retinal diseases","volume":"6","author":"Ng","year":"2014","journal-title":"World J Stem Cells"},{"key":"10.1038\/mt.2016.12_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s13311-011-0075-8","article-title":"Cellular therapy and induced neuronal replacement for Huntington's disease","volume":"8","author":"Benraiss","year":"2011","journal-title":"Neurotherapeutics"},{"key":"10.1038\/mt.2016.12_bib55","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.stem.2013.04.014","article-title":"Sustained mobilization of endogenous neural progenitors delays disease progression in a transgenic model of Huntington's disease","volume":"12","author":"Benraiss","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1038\/mt.2016.12_bib56","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/stem.1508","article-title":"Transplants of adult mesenchymal and neural stem cells provide neuroprotection and behavioral sparing in a transgenic rat model of Huntington's disease","volume":"32","author":"Rossignol","year":"2014","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2016.12_bib57","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","article-title":"Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes","volume":"217","author":"Rossignol","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1038\/mt.2016.12_bib58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/00207450390207759","article-title":"Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes","volume":"113","author":"Lescaudron","year":"2003","journal-title":"Int J Neurosci"},{"key":"10.1038\/mt.2016.12_bib59","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1179\/174313209X409025","article-title":"Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum","volume":"32","author":"Edalatmanesh","year":"2010","journal-title":"Neurol Res"},{"key":"10.1038\/mt.2016.12_bib60","doi-asserted-by":"crossref","first-page":"e9347","DOI":"10.1371\/journal.pone.0009347","article-title":"Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease","volume":"5","author":"Snyder","year":"2010","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.12_bib61","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.12_bib62","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1128\/JVI.69.2.748-755.1995","article-title":"Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells","volume":"69","author":"Challita","year":"1995","journal-title":"J Virol"},{"key":"10.1038\/mt.2016.12_bib63","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2012-02-400937","article-title":"Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans","volume":"120","author":"Candotti","year":"2012","journal-title":"Blood"},{"key":"10.1038\/mt.2016.12_bib64","first-page":"181","article-title":"The psychopathology of Huntington's disease","volume":"69","author":"Folstein","year":"1991","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"10.1038\/mt.2016.12_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11920-996-0030-2","article-title":"An overview of psychiatric symptoms in Huntington's disease","volume":"3","author":"Anderson","year":"2001","journal-title":"Curr Psychiatry Rep"},{"key":"10.1038\/mt.2016.12_bib66","first-page":"219","article-title":"Behavioral changes in Huntington Disease","volume":"14","author":"Craufurd","year":"2001","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"10.1038\/mt.2016.12_bib67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","article-title":"Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis","volume":"198","author":"Crigler","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2016.12_bib68","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.65.6.753","article-title":"Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis","volume":"65","author":"Kassis","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1038\/mt.2016.12_bib69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5966\/sctm.2014-0060","article-title":"Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions","volume":"4","author":"Berry","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1038\/mt.2016.12_bib70","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/stem.1729","article-title":"Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?","volume":"32","author":"Moll","year":"2014","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2016.12_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/sj.gt.3302417","article-title":"Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE)","volume":"12","author":"Kingsman","year":"2005","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2016.12_bib72","doi-asserted-by":"crossref","first-page":"e84726","DOI":"10.1371\/journal.pone.0084726","article-title":"Correlations of behavioral deficits with brain pathology assessed through longitudinal MRI and histopathology in the R6\/1 mouse model of Huntington's disease","volume":"8","author":"Rattray","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2016.12_bib73","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2015.01.002","article-title":"Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease","volume":"76","author":"Southwell","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1038\/mt.2016.12_bib74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/hmg\/dds397","article-title":"A fully humanized transgenic mouse model of Huntington disease","volume":"22","author":"Southwell","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1038\/mt.2016.12_bib75","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1111\/jth.12933","article-title":"Mesenchymal stem cell treatment for hemophilia: a review of current knowledge","volume":"13 Suppl 1","author":"Sokal","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1038\/mt.2016.12_bib76","doi-asserted-by":"crossref","first-page":"974","DOI":"10.5966\/sctm.2015-0071","article-title":"Our fat future: translating adipose stem cell therapy","volume":"4","author":"Nordberg","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"10.1038\/mt.2016.12_bib77","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/1744666X.2015.1029458","article-title":"Efficacy of immunotherapy with mesenchymal stem cells in man: a systematic review","volume":"11","author":"Luk","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1038\/mt.2016.12_bib78","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/14653240701883061","article-title":"A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury","volume":"10","author":"Zhang","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1038\/mt.2016.12_bib79","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.06.011","article-title":"Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial","volume":"23","author":"D\u00edez-Tejedor","year":"2014","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"Pt B","key":"10.1038\/mt.2016.12_bib80","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.brainres.2015.06.035","article-title":"Neural and glial progenitor transplantation as a neuroprotective strategy for amyotrophic lateral sclerosis (ALS)","volume":"1628","author":"Haidet-Phillips","year":"2015","journal-title":"Brain Res"},{"key":"10.1038\/mt.2016.12_bib81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2014.02.021","article-title":"The past, present and future of stem cell clinical trials for ALS","volume":"262 Pt B","author":"Thomsen","year":"2014","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2016.12_bib82","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1007\/s00018-014-1613-4","article-title":"Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation","volume":"71","author":"Faravelli","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.1038\/mt.2016.12_bib83","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","article-title":"Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease","volume":"155","author":"Venkataramana","year":"2010","journal-title":"Transl Res"},{"key":"10.1038\/mt.2016.12_bib84","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/trf.12421","article-title":"Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices","volume":"54","author":"Sharma","year":"2014","journal-title":"Transfusion"},{"key":"10.1038\/mt.2016.12_bib85","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1474-4422(09)70278-9","article-title":"Neural grafts in Huntington's disease: viability after 10 years","volume":"8","author":"Bachoud-L\u00e9vi","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1038\/mt.2016.12_bib86","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1089\/10430340050111377","article-title":"Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF","volume":"11","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2016.12_bib87","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington's disease 6 years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-L\u00e9vi","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1038\/mt.2016.12_bib88","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(00)03310-9","article-title":"Motor and cognitive improvements in patients with Huntington's disease after neural transplantation","volume":"356","author":"Bachoud-L\u00e9vi","year":"2000","journal-title":"Lancet"},{"issue":"Pt 1","key":"10.1038\/mt.2016.12_bib89","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/awh003","article-title":"Striatal neural grafting improves cortical metabolism in Huntington's disease patients","volume":"127","author":"Gaura","year":"2004","journal-title":"Brain"},{"key":"10.1038\/mt.2016.12_bib90","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/MOT.0b013e32834c2356","article-title":"Clinical translation of cell transplantation in the brain","volume":"16","author":"Dunnett","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1038\/mt.2016.12_bib91","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/B978-0-12-381328-2.00017-1","article-title":"Cell-based treatments for huntington's disease","volume":"98","author":"Dunnett","year":"2011","journal-title":"Int Rev Neurobiol"},{"key":"10.1038\/mt.2016.12_bib92","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00441-007-0488-1","article-title":"Human stem cells for CNS repair","volume":"331","author":"Zietlow","year":"2008","journal-title":"Cell Tissue Res"},{"key":"10.1038\/mt.2016.12_bib93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.expneurol.2006.11.007","article-title":"Stem cell transplantation for Huntington's disease","volume":"203","author":"Dunnett","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2016.12_bib94","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.bbrc.2004.05.021","article-title":"Adipogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice-including relationship of sex differences","volume":"319","author":"Ogawa","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2016.12_bib95","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mcn.2011.12.001","article-title":"Examination of mesenchymal stem cell-mediated RNAi transfer to Huntington's disease affected neuronal cells for reduction of huntingtin","volume":"49","author":"Olson","year":"2012","journal-title":"Mol Cell Neurosci"},{"key":"10.1038\/mt.2016.12_bib96","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/stem.1976","article-title":"Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo","volume":"33","author":"Beegle","year":"2015","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2016.12_bib97","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1634\/stemcells.2007-1104","article-title":"Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells","volume":"26","author":"Rosov\u00e1","year":"2008","journal-title":"Stem Cells"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616302234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T20:12:10Z","timestamp":1718309530000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616302234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1525001616302234"],"URL":"https:\/\/doi.org\/10.1038\/mt.2016.12","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}